Stocks and Investing Stocks and Investing
Wed, August 31, 2022
Tue, August 30, 2022

Michael Ulz Downgraded (CABA) to Hold and Decreased Target to $3 on, Aug 30th, 2022


Published on 2024-10-27 22:51:40 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Downgraded "Cabaletta Bio, Inc." (CABA) to Hold and Decreased Target from $15 to $3 on, Aug 30th, 2022.

Michael has made no other calls on CABA in the last 4 months.



There are 2 other peers that have a rating on CABA. Out of the 2 peers that are also analyzing CABA, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael


  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $13 on, Friday, August 12th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, May 25th, 2022
Contributing Sources